18/10/2024
ANZOS has always been a welcome home for MHS, with a fantastic mix of basic scientists and expert clinicians. Our new Metabolic Health Platform METS_IQ, attracted a lot of interest particularly in regards to personalisation of lifestyle management.
There were also a number of enquiries for ECAL in relation to monitoring for metabolic adaptation with the new obesity medicines.